Screening for Hepatitis C Virus (HCV) Infection in Acute Lymphoblastic Leukemia (ALL) Survivors in The Hematology and Oncology Department of Children Hospital Zagazig University | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 17, Volume 80, Issue 1, July 2020, Pages 662-665 PDF (569.14 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2020.93891 | ||
| Authors | ||
| Laila Metwaly Sherief1; Mohamed AbdelKader Elmalky1; Sameh Saber Bayoumi2; Sherif Mamdoh Talat* 1 | ||
| 1Department of Pediatrics, Faculty of Medicine, Zagazig University | ||
| 2Department of Radiology, Faculty of Medicine, Zagazig University | ||
| Abstract | ||
| Background: Acute lymphoblastic leukemia (ALL) survivors received blood transfusions for multiple times during treatment are at great risk for HCV infection. Rapid progression to cirrhosis in those patients is a concern for cancer survivors because of the immunosuppression from cancer-related treatment. Objective: Our study aimed to screen for (HCV) infection in acute lymphoblastic leukemia (ALL) survivors. Patients and methods: This cross-sectional study was conducted in the Hematology and Oncology Department of Children Hospital-Zagazig University on 80 cancer survivors collected over a period of 6 months from September 2018 to February 2019. Results: 70% of ALL survivors were HCV positive. Conclusion: ALL survivors are at great risk for acquiring HCV infection from the repeated blood and blood products transfusions with supsequent development of liver comorbitidites later on. | ||
| Keywords | ||
| HCV; ALL Childhood cancer | ||
|
Statistics Article View: 409 PDF Download: 620 |
||
